Portal Hypertension

Introduction

If you or a family member has recently been told about portal hypertension, you are not alone in finding the term confusing. Many people first hear it after a hospital admission for vomiting blood, abdominal swelling, or an abnormal ultrasound or scan. Others learn about it during follow-up for chronic liver disease, hepatitis, or fatty liver. Either way, the diagnosis usually arrives alongside a lot of new information about the liver, the blood vessels around it, and what needs to happen next.

Portal hypertension is not a disease on its own. It is a consequence of something else — most often long-standing liver disease — that raises the pressure inside a specific group of veins around the liver. That pressure is what drives the most serious complications, including bleeding from enlarged veins (varices) and fluid build-up in the abdomen (ascites). The good news is that there is now a clear, evidence-based framework for managing portal hypertension at every stage, from early and well-compensated disease to advanced complications.

This guide explains what portal hypertension is, what causes it, how it is diagnosed, and the range of treatments that doctors use today — including medications, endoscopic procedures, interventional radiology techniques such as TIPS, surgical shunts, and liver transplantation. It is written for someone who already has the diagnosis or is being investigated, and who wants to understand the road ahead.

What Is Portal Hypertension?

The portal vein is a large blood vessel that carries blood from the stomach, intestines, spleen, and pancreas to the liver. The liver filters this blood, processes nutrients, and removes toxins before the blood returns to the heart. In a healthy liver, blood flows through this system at low pressure.

In portal hypertension, that pressure rises. This usually happens because something inside or around the liver is blocking or resisting the normal flow of blood. When the pressure builds up, blood begins to back up and find other ways to return to the heart. It does this by flowing through smaller veins that were not designed to carry that much blood. Over time, these smaller veins become swollen and fragile. The most well-known examples are varices in the lower oesophagus (food pipe) and stomach, which can bleed dangerously.

Doctors measure portal pressure using a value called the hepatic venous pressure gradient (HVPG). Clinically significant portal hypertension is generally defined as an HVPG of 10 mmHg or more. Above this level, the risk of complications such as variceal bleeding and ascites starts to rise meaningfully. Above 12 mmHg, the risk of bleeding rises further. These numbers help your hepatologist (liver specialist) decide how aggressively to treat.

Portal hypertension is described as “compensated” when there is raised pressure but no major complications yet, and “decompensated” once complications such as variceal bleeding, ascites, or hepatic encephalopathy appear. The shift from compensated to decompensated is an important turning point in the disease, and much of modern treatment aims to delay or prevent it.

Types of Portal Hypertension

Prehepatic (before the liver)

Here the blockage is in the portal vein itself, before it enters the liver. The most common cause is portal vein thrombosis — a clot in the portal vein. The liver itself may be relatively healthy, especially in younger patients. This pattern is more common in children, where it is often called extrahepatic portal vein obstruction (EHPVO).

Intrahepatic (within the liver)

This is by far the most common type and is usually caused by cirrhosis. The scar tissue of cirrhosis distorts the liver’s internal architecture and obstructs blood flow at the level of the tiny sinusoids inside the liver. Other intrahepatic causes include schistosomiasis (a parasitic infection), advanced fatty liver disease, and a less common condition called non-cirrhotic portal fibrosis, which is seen relatively frequently in parts of South Asia.

Posthepatic (after the liver)

Here the problem is in the veins that drain blood out of the liver towards the heart. Budd-Chiari syndrome, in which the hepatic veins become blocked, is a classic example. Severe right-sided heart failure or constrictive pericarditis can also raise pressure in this part of the system.

Knowing the type guides investigation and treatment. For example, prehepatic portal hypertension from a portal vein clot may be treated with anticoagulation (blood thinners), while intrahepatic portal hypertension from cirrhosis focuses on lowering portal pressure, preventing variceal bleeding, and managing the underlying liver disease.

Causes and Risk Factors

Portal hypertension almost always reflects an underlying problem with the liver or its blood vessels. Identifying the cause is one of the first tasks for the medical team.

Common causes

• Cirrhosis from chronic liver disease. This is the most common cause worldwide. Cirrhosis itself can develop from chronic hepatitis B or C, long-term heavy alcohol use, metabolic dysfunction-associated steatotic liver disease (MASLD, previously called non-alcoholic fatty liver disease), autoimmune hepatitis, and inherited conditions such as Wilson’s disease, haemochromatosis, and alpha-1 antitrypsin deficiency.
• Portal vein thrombosis. A clot in the portal vein can cause portal hypertension even when the liver itself is healthy.
• Schistosomiasis. A parasitic infection that affects the liver’s small blood vessels; an important cause in some regions.
• Non-cirrhotic portal fibrosis / idiopathic non-cirrhotic portal hypertension. Causes raised pressure without the typical features of cirrhosis.
• Budd-Chiari syndrome. Blockage of the hepatic veins, sometimes linked to underlying blood-clotting disorders.
• Congenital liver and vascular abnormalities, particularly in children.

Risk factors

• Chronic hepatitis B or C infection
• Long-term heavy alcohol intake
• Obesity, type 2 diabetes, and metabolic syndrome (driving fatty liver disease)
• Underlying blood-clotting disorders (which can predispose to portal vein thrombosis or Budd-Chiari syndrome)
• Family history of inherited liver disease
• Previous abdominal infections, surgery, or pancreatitis in some cases of portal vein thrombosis

In its early stages, portal hypertension often causes no symptoms at all. Many people are diagnosed only when a complication develops or when imaging done for another reason picks up signs such as an enlarged spleen or visible collateral veins.

As the condition progresses, the symptoms typically reflect either the underlying liver disease or the specific complications of raised portal pressure.

Signs that may suggest portal hypertension

• An enlarged spleen, sometimes felt as fullness or discomfort in the upper left abdomen
• Low platelet count or reduced white blood cells on a blood test (because the enlarged spleen traps these cells)
• Visible veins on the abdomen (sometimes called “caput medusae”)
• Easy bruising or bleeding, partly from low platelets and partly from impaired liver function

Symptoms of complications

• Variceal bleeding can present as vomiting bright red blood, vomit that looks like coffee grounds, or passing black, tarry stools (melena). This is a medical emergency.
• Ascites — fluid build-up in the abdomen — causes progressive swelling, tight clothing around the waist, weight gain, breathlessness, and early fullness when eating.
• Hepatic encephalopathy can cause confusion, daytime sleepiness, disturbed sleep, personality changes, slowed thinking, or, in severe cases, drowsiness progressing to unconsciousness.
• Swelling of the legs may accompany ascites.
• Breathlessness can occur if a large volume of fluid pushes up on the diaphragm or if a complication called hepatopulmonary syndrome develops.

If you have been diagnosed with portal hypertension, recognising these warning signs — particularly the signs of bleeding — is one of the most important parts of self-care. Bleeding from varices is one of the few situations where every hour matters.

Diagnosis

Most people with portal hypertension are evaluated by a hepatologist or gastroenterologist. The aim is to confirm raised portal pressure, identify the underlying cause, and assess the severity of liver disease and the risk of complications.

Blood tests

• Liver function tests (ALT, AST, ALP, bilirubin, albumin)
• Full blood count, which often shows low platelets and sometimes low white blood cells or anaemia
• Tests of clotting (prothrombin time, INR)
• Kidney function and electrolytes
• Hepatitis B and C testing
• Tests for autoimmune liver disease, iron overload, Wilson’s disease, and other specific causes when clinically suggested

Imaging

• Ultrasound with Doppler is usually the first imaging test. It looks at the liver, spleen, and blood flow direction and speed in the portal vein. Reversal of flow, a slow flow, or an obvious clot can all support the diagnosis.
• CT or MRI scans give detailed pictures of the liver, the portal venous system, and any collateral veins. They are also used to screen for liver cancer in patients with cirrhosis.
• Transient elastography (FibroScan) and other non-invasive measures of liver stiffness help estimate fibrosis and the likelihood of clinically significant portal hypertension.

Endoscopy

An upper gastrointestinal endoscopy — a thin camera passed through the mouth into the oesophagus and stomach — is the standard way to look for varices and assess their size and risk of bleeding. Current Baveno VII guidance suggests that not every patient needs endoscopy at diagnosis: in selected patients with low liver stiffness and normal platelet counts, endoscopy can sometimes be deferred. Your specialist will decide based on your specific findings.

Measuring portal pressure

The hepatic venous pressure gradient (HVPG) is measured by passing a thin catheter through a vein in the neck or groin into the hepatic vein. It is the most accurate way to quantify portal pressure but is not done routinely everywhere. It is most useful in specific situations — for example, before certain surgical decisions, in research settings, or when the picture is unclear.

Treatment and Management

Treatment of portal hypertension has several goals that run in parallel: treating the underlying liver disease, lowering portal pressure, preventing first bleeding from varices, stopping active bleeding, preventing repeat bleeding, managing ascites and other complications, and, where appropriate, planning for liver transplantation. The choice of treatment depends on the cause, the stage of liver disease, and what complications have appeared.

Treating the underlying cause

Wherever possible, the cause of the liver disease is treated directly. Examples include:

• Antiviral therapy for hepatitis B or C
• Complete abstinence from alcohol in alcohol-related liver disease
• Weight loss, blood sugar control, and metabolic management in MASLD
• Immunosuppressive therapy for autoimmune hepatitis
• Anticoagulation (blood thinners) for portal vein thrombosis or Budd-Chiari syndrome in suitable patients

Effective treatment of the underlying disease can sometimes reduce portal pressure and, in selected cases, partially reverse early fibrosis.

Medications to lower portal pressure

The mainstay of medical therapy is a group of medicines called non-selective beta-blockers, including propranolol, nadolol, and carvedilol. These medicines reduce blood flow into the portal system and lower portal pressure. Current Baveno VII guidance and major hepatology societies favour carvedilol in many situations because it appears to lower portal pressure more effectively than older beta-blockers and may be useful even before varices are seen, in patients with clinically significant portal hypertension.

Beta-blockers are not suitable for everyone. People with very low blood pressure, certain heart rhythm problems, severe asthma, or refractory ascites may not be candidates. The dose is usually titrated based on heart rate, blood pressure, and tolerance.

Endoscopic treatment of varices

Endoscopy plays a central role in preventing and treating variceal bleeding:

• Endoscopic variceal band ligation (EVL) places small rubber bands around individual varices to cut off their blood supply. The varices then shrink and fall off. EVL is the main endoscopic option for medium and large oesophageal varices.
• Endoscopic sclerotherapy involves injecting a chemical into or beside varices to scar them. It is used less often for oesophageal varices today but remains useful in some situations, particularly for gastric varices, where tissue adhesives such as cyanoacrylate glue may be injected.

Endoscopic treatment is used both to prevent first bleeding in higher-risk patients (often combined with beta-blockers) and to stop active bleeding during an emergency. After a bleeding episode, repeat sessions are usually scheduled until the varices are eradicated, followed by long-term surveillance.

Transjugular intrahepatic portosystemic shunt (TIPS)

TIPS is used in several situations:

• To stop variceal bleeding that does not respond to medications and endoscopy
• As an early intervention in selected high-risk patients soon after a variceal bleed (sometimes called “pre-emptive” or “early” TIPS)
• To control ascites that does not respond to diuretics (“refractory ascites”)
• In some cases of hepatic hydrothorax (fluid around the lung from liver disease) or Budd-Chiari syndrome

The main risk of TIPS is worsening hepatic encephalopathy, because some toxins now bypass the liver. Careful patient selection is essential, and patients are followed closely after the procedure.

Surgical shunts and devascularisation

Before TIPS became widely available, surgical shunts (such as distal splenorenal shunts) were a key option to redirect blood and reduce portal pressure. These operations are still used in selected patients — for example, in some cases of non-cirrhotic portal hypertension, in children with extrahepatic portal vein obstruction (such as the Meso-Rex bypass), or where TIPS is not feasible. Devascularisation procedures, which disconnect bleeding-prone varices from the high-pressure system, may also be used in specific situations.

Liver transplantation

When portal hypertension reflects advanced cirrhosis with repeated complications, declining liver function, or both, liver transplantation may be considered. Transplant replaces the diseased liver with a healthy one from a deceased or living donor and effectively cures portal hypertension caused by cirrhosis. Eligibility depends on the cause and severity of liver disease, overall health, and detailed assessment by a transplant team.

Managing ascites

For ascites, the standard approach combines:

• A reduced-salt diet
• Diuretic medications such as spironolactone, sometimes combined with furosemide
• Therapeutic paracentesis (draining fluid through a needle) when ascites is large or causing breathlessness
• Albumin replacement during large-volume drainage in many patients with cirrhosis
• TIPS or, less commonly, peritoneo-venous shunts in refractory cases

Managing hepatic encephalopathy

Hepatic encephalopathy is treated with lactulose, sometimes combined with rifaximin (an antibiotic that reduces gut bacteria producing ammonia). Triggers such as infection, dehydration, constipation, and bleeding are looked for and treated. Family members are often taught to recognise early signs — subtle confusion, day-night reversal, or unusual behaviour — so that treatment can start early.

Lifestyle and Self-Management

Day-to-day choices matter a great deal in portal hypertension, both because they support the underlying liver and because they reduce the risk of complications.

Alcohol

Complete avoidance of alcohol is recommended in any form of advanced liver disease, regardless of whether alcohol was the original cause. Even small amounts can accelerate liver injury.

Diet and nutrition

• Salt restriction is one of the most important measures for anyone with ascites or a tendency to fluid retention. Most guidance suggests limiting sodium to around 2 g (5 g of salt) per day, but your specialist will give a specific target.
• Adequate protein is important. Older advice to restrict protein in encephalopathy has largely been replaced by guidance to maintain normal protein intake (often 1.2–1.5 g/kg/day), with adjustments only in specific situations. Malnutrition and muscle loss (sarcopenia) are common in cirrhosis and are linked to worse outcomes.
• Small, frequent meals, including a late evening snack, help reduce overnight muscle breakdown.
• A varied diet rich in vegetables, fruits, whole grains, and lean protein supports overall nutrition. Specific restrictions depend on individual needs — a dietitian familiar with liver disease can be very helpful.

Medications to use with care

Some everyday medicines can worsen portal hypertension or its complications. Examples include non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and diclofenac, which can affect kidney function and increase bleeding risk in advanced liver disease. Sedatives, sleeping tablets, and strong painkillers can precipitate encephalopathy. Any new medicine — including herbal and over-the-counter products — should be reviewed by your hepatologist.

Vaccinations and infection prevention

Infections can trigger sudden worsening in cirrhosis. Vaccinations against hepatitis A and B, influenza, pneumococcal disease, and COVID-19 are generally recommended in chronic liver disease. Promptly treating any infection — including urinary, chest, or skin infections — is important.

Exercise and activity

Moderate, regular physical activity helps maintain muscle mass and overall health. Very strenuous activity, heavy lifting, or contact sports may need to be limited, particularly in people with large varices or a markedly enlarged spleen. Your specialist can advise on what is reasonable for you.

Monitoring and Follow-up

Portal hypertension is a long-term condition, and structured follow-up is one of the strongest tools to prevent complications.

What follow-up usually involves

• Regular clinic reviews with a hepatologist or gastroenterologist
• Blood tests every few months to check liver function, kidney function, electrolytes, and blood counts
• Ultrasound of the liver, often every six months, to monitor the liver and screen for liver cancer in patients with cirrhosis (often combined with the blood test alpha-fetoprotein)
• Endoscopy at intervals decided by the size and risk of varices, the response to treatment, and the stage of liver disease
• Periodic measurement of liver stiffness in some patients
• Review of medications, diet, and vaccination status

The exact intervals are individualised. Someone with stable, compensated cirrhosis and no varices may be seen less often than someone who has had a recent bleed, refractory ascites, or new encephalopathy.

Complications

The most important reason to treat portal hypertension is to prevent or limit its complications.

Variceal bleeding

Bleeding from oesophageal or gastric varices is the most dramatic and life-threatening complication. Prevention through beta-blockers and/or endoscopic band ligation, prompt recognition of bleeding symptoms, and access to emergency endoscopy are the cornerstones of management.

Ascites and spontaneous bacterial peritonitis

Ascites is common in advanced cirrhosis. A specific infection of the ascitic fluid, called spontaneous bacterial peritonitis (SBP), can develop without an obvious source and requires urgent antibiotic treatment. People who have had SBP usually need long-term preventive antibiotics.

Hepatic encephalopathy

This can range from mild changes in concentration to severe confusion or coma. Many episodes are triggered by something specific — constipation, infection, dehydration, bleeding, certain medicines — that can be treated.

Hepatorenal syndrome

A serious form of kidney dysfunction that can develop in advanced cirrhosis. It is treated in hospital with specific medications and supportive care, and is one of the situations where liver transplantation may be considered urgently.

Hepatopulmonary syndrome and portopulmonary hypertension

Liver disease can affect the lungs in two distinct ways: hepatopulmonary syndrome, where abnormal blood vessels in the lungs cause low oxygen levels, and portopulmonary hypertension, where pressure in the lung arteries rises. Both are uncommon but important to recognise.

Liver cancer (hepatocellular carcinoma)

Cirrhosis — the commonest underlying cause of portal hypertension — is also the main risk factor for liver cancer. This is why six-monthly ultrasound surveillance is standard in most patients with cirrhosis.

Living with Portal Hypertension

For many people, portal hypertension becomes a long-term part of life rather than a short crisis. With consistent treatment of the underlying liver disease, attention to diet and medications, and regular monitoring, many patients live for years with stable disease.

Practical day-to-day tips

• Keep an up-to-date list of your medications, doses, and recent test results to share with any new doctor or in an emergency.
• Make sure close family members know your diagnosis and what to watch for, particularly signs of bleeding or encephalopathy.
• Weigh yourself regularly at home if you have a tendency to ascites; a rapid weight gain often signals fluid build-up before swelling becomes obvious.
• Plan ahead for travel: carry a summary of your condition, know where the nearest hospital is, and avoid long gaps in medication.
• Tell any new doctor or dentist about your liver disease and portal hypertension before they prescribe new medicines.

Emotional and psychological wellbeing

Living with a chronic liver condition can be emotionally demanding, particularly after a serious event like a variceal bleed or a hospital admission for encephalopathy. Anxiety, low mood, and worry about the future are common. Talking to your hepatology team, finding a counsellor or support group, and involving your family can all help. These conversations are part of good care, not separate from it.

Portal Hypertension in Children

Portal hypertension in children has some important differences from the adult form. The most common cause in many parts of the world, including South Asia, is extrahepatic portal vein obstruction (EHPVO) — a blockage of the portal vein outside the liver. In these children, the liver itself is often relatively well preserved. Other paediatric causes include biliary atresia (a condition of the bile ducts present from birth), congenital hepatic fibrosis, autoimmune liver disease, and inherited metabolic disorders.

Children may come to attention with an enlarged spleen, low platelets discovered on a routine blood test, abdominal swelling, or an episode of variceal bleeding. Because the underlying biology can differ from adults, paediatric hepatology teams approach diagnosis and treatment carefully.

Treatment principles overlap with adult care but with some specific considerations:

• Treating the underlying disease (for example, surgery for biliary atresia) is central.
• Endoscopic band ligation and sclerotherapy are used to manage varices, with size and shape of the equipment adapted for children.
• For EHPVO, a surgical option called the Meso-Rex bypass — which restores blood flow into the liver — may be considered in suitable children at specialised centres.
• TIPS is used selectively in children and usually at centres with paediatric expertise.
• Liver transplantation is considered in children with progressive liver failure or complications that cannot be controlled by other means.
• Nutrition, growth, and development need close attention; children with chronic liver disease are at risk of falling behind in growth.
• Schooling, vaccination, and emotional support for the child and family are part of long-term care.

If you are a parent navigating this diagnosis, asking the team to explain each step in plain language — and bringing another adult to consultations when possible — can help you absorb and remember the information.

Preventing Progression and Complications

Prevention in portal hypertension means slowing the underlying liver disease and lowering the risk of complications such as bleeding, ascites, and encephalopathy.

• Stick to scheduled appointments and tests, even when you feel well.
• Take medications as prescribed and do not stop beta-blockers, diuretics, or lactulose without medical advice.
• Avoid alcohol entirely.
• Manage weight, blood sugar, blood pressure, and cholesterol if you have metabolic risk factors.
• Stay up to date with recommended vaccinations.
• Treat infections promptly.
• Be cautious with over-the-counter painkillers, sedatives, and herbal products; check before using.
• Maintain good nutrition, including adequate protein, and avoid extreme diets.

When to Seek Urgent Care

Some symptoms in portal hypertension are emergencies. Seek immediate medical care — ideally at a hospital with experience in liver disease — if you experience:

• Vomiting blood or material that looks like coffee grounds
• Passing black, tarry stools or fresh blood from the rectum
• Sudden, severe abdominal pain or a rapidly swelling abdomen
• Fever with abdominal pain, particularly if you have ascites
• Confusion, marked drowsiness, disorientation, or unusual behaviour
• Sudden breathlessness
• A noticeable reduction in urine output

If you have known varices and have been given clear instructions by your team about what to do in an emergency, follow those instructions.

Frequently Asked Questions

Is portal hypertension curable?

Portal hypertension itself is usually a feature of an underlying liver problem. In some situations — for example, when a portal vein clot is treated successfully, or when liver transplantation replaces a cirrhotic liver — portal pressure can return towards normal. In most patients with established cirrhosis, the aim is long-term control and prevention of complications rather than cure.

Can portal hypertension improve with treatment?

Yes, especially when the underlying cause can be addressed. Treating chronic hepatitis, stopping alcohol, losing weight in fatty liver disease, and effective use of beta-blockers can all lower portal pressure and reduce the risk of complications.

Do I always need endoscopy?

Not always at diagnosis. Current Baveno VII guidance allows endoscopy to be deferred in selected patients with low liver stiffness and normal platelet counts, while others — particularly those with more advanced disease — benefit from earlier endoscopy. Your hepatologist will tailor this to your case.

Will I need TIPS or a liver transplant?

Most people with portal hypertension are managed with a combination of medication, lifestyle measures, and, when needed, endoscopic treatment. TIPS, surgical shunts, and transplant are reserved for specific situations — such as bleeding that cannot be controlled by other means, refractory ascites, or advanced liver failure. Whether any of these apply to you depends on detailed assessment.

Can I exercise with portal hypertension?

Moderate physical activity is generally encouraged, because it helps maintain muscle mass and overall health. Very heavy lifting and intense straining may need to be limited, especially with large varices or a markedly enlarged spleen. Ask your specialist what is appropriate for your situation.

Is it safe to fly or travel long distances?

Many people with stable, compensated portal hypertension can travel, including by air. People with recent bleeding, severe ascites, encephalopathy, or active complications may be advised to delay travel. Planning ahead — carrying medications, knowing where care is available, and having a summary of your medical history — helps reduce risk.

How often will I need follow-up?

Follow-up intervals depend on the stage of liver disease, whether varices are present, and whether complications have occurred. Many patients are reviewed every three to six months, with blood tests, ultrasound surveillance for liver cancer in those with cirrhosis, and endoscopy at intervals decided by their specialist.

Can pregnancy be considered with portal hypertension?

Pregnancy in portal hypertension carries higher risk and needs careful planning with both a hepatologist and an obstetrician experienced in high-risk pregnancy. Screening and management of varices before and during pregnancy, and a plan for delivery, are central to safe care.

Conclusion

Portal hypertension is a serious but manageable condition. It almost always reflects an underlying liver problem, and modern care brings together treatment of that underlying disease, medications to lower portal pressure, endoscopic care of varices, interventional procedures such as TIPS where needed, and liver transplantation in selected patients. Lifestyle measures, careful nutrition, and structured long-term follow-up are just as important as any single procedure.

If you have been diagnosed with portal hypertension, the most useful steps are to understand your specific cause, follow your treatment plan, learn the warning signs of complications, and stay in regular contact with a hepatology team. With consistent care, many people live well for many years with this condition, and the range of effective treatments continues to grow.